Balchem Corp. VP Sells $756,675 in Stock (BCPC)
Balchem Corp. (NASDAQ:BCPC) VP David F. Ludwig sold 13,500 shares of the stock on the open market in a transaction dated Friday, January 10th. The stock was sold at an average price of $56.05, for a total transaction of $756,675.00. Following the completion of the sale, the vice president now directly owns 31,025 shares of the company’s stock, valued at approximately $1,738,951. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Separately, analysts at DA Davidson raised their price target on shares of Balchem Corp. from $57.00 to $65.00 in a research note to investors on Wednesday, November 6th. They now have a “buy” rating on the stock.
Shares of Balchem Corp. (NASDAQ:BCPC) traded down 0.32% on Monday, hitting $56.37. The stock had a trading volume of 113,179 shares. Balchem Corp. has a 52 week low of $35.79 and a 52 week high of $59.97. The stock’s 50-day moving average is $57.79 and its 200-day moving average is $52.85. The company has a market cap of $1.699 billion and a P/E ratio of 39.27.
Balchem Corp. (NASDAQ:BCPC) last announced its earnings results on Tuesday, November 5th. The company reported $0.38 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.41 by $0.03. The company had revenue of $87.59 million for the quarter, compared to the consensus estimate of $86.75 million. On average, analysts predict that Balchem Corp. will post $1.48 earnings per share for the current fiscal year.
The company also recently announced a annual dividend, which is scheduled for Tuesday, January 21st. Stockholders of record on Monday, December 23rd will be paid a dividend of 0.26 per share. This represents a dividend yield of 0.45%. The ex-dividend date is Thursday, December 19th. This is a boost from Balchem Corp.’s previous annual dividend of $0.22.
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.